
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
ByHeart baby formula from all lots may be contaminated with botulism bacteria, tests show25.11.2025 - 2
Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'30.11.2025 - 3
6 Exceptionally Appraised Summer Travel Objections06.06.2024 - 4
10 Setting up camp Shelters That Offer Both Excellence and Isolation05.06.2024 - 5
Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.12.01.2026
Shooting of MIT professor Nuno Loureiro has police searching for a suspect
Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
Novo Nordisk gears up for December Ozempic launch in India, sources say
Step by step instructions to Keep up with the Life span of Your Kona SUV's Battery Duration
Step by step instructions to Streamline Your Dozing Involvement in a Savvy Bed
Are IDF reservists properly armed during post-war operations?
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
From School Dropout to Example of overcoming adversity: My Excursion
The 10 Most Compelling Forerunners in Innovation












